Patients age 50 or over with a fragility fracture who have either a dual-energy X-Ray absorptiometry (DXA) scan ordered or performed, or a prescription for FDA-approved pharmacotherapy for osteoporosis, or who are seen by or linked to a fracture liaison service prior to discharge from inpatient status,. If DXA is not available and documented as such, then any other specified fracture risk assessment method may be ordered or performed.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients who had either a DXA scan ordered or performed, OR a prescription for FDA-approved pharmacotherapy for osteoporosis treatment, OR those who were seen by, contacted by, or linked to a fracture liaison service prior to discharge OR had other fracture risk assessment method ordered or performed if DXA is not available.
-
1.15 Denominator
Patients age 50 and over discharged from inpatient status with an ICD-10-CM Principal or Other Diagnosis Code of selected fractures as defined in Table 3.1 Vertebral Fracture, Table 4.1 Hip Fracture, or Table 5.1 Other Fracture,
-
Exclusions
• Age less than 50 years
• “Comfort Measures Only” documented
• Enrollment in a clinical trial pertaining to osteoporosis
• On FDA-Approved pharmacotherapy for osteoporosis treatment as defined in Table 1.1 prior to the fracture date
• Bone Mineral density test documented in the 12 months prior to the fracture
• Expired
See attached Excel file for definitions
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Primary Care and Chronic Illness Fall Cycle 2017Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization EmailSteward Organization Copyright
This measure resides in the public domain and is not copyrighted
-
-
-
Risk Adjustment
-